|
Market Closed -
Nasdaq
21:00:00 05/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 7.730 USD | +1.84% |
|
-9.06% | -26.38% |
| 10-02 | Nanobiotix Names New Finance Chief | MT |
| 10-01 | Nanobiotix Appoints Arnd Christ as CFO | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.06B | - | ||||
| 74.31B | |||||
| 56.95B | |||||
| 48.3B | |||||
| 44.51B | - | - | - | - | - |
| 43.8B |
- Stock Market
- Stocks
- IMTX Stock
- Charts Immatics N.V.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
